These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27012733)

  • 1. CAMKK2, Regulated by Promoter Methylation, is a Prognostic Marker in Diffuse Gliomas.
    Liu DM; Wang HJ; Han B; Meng XQ; Chen MH; Yang DB; Sun Y; Li YL; Jiang CL
    CNS Neurosci Ther; 2016 Jun; 22(6):518-24. PubMed ID: 27012733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients.
    Mur P; Rodríguez de Lope Á; Díaz-Crespo FJ; Hernández-Iglesias T; Ribalta T; Fiaño C; García JF; Rey JA; Mollejo M; Meléndez B
    J Neurooncol; 2015 May; 122(3):441-50. PubMed ID: 25682093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of HTATIP2 expression is associated with promoter methylation and poor prognosis in glioma.
    Dong X; Deng Q; Nie X; Zhang M; Jia W; Chen C; Xu C; Xu R
    Exp Mol Pathol; 2015 Apr; 98(2):192-9. PubMed ID: 25617528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas.
    Kim HS; Kwon MJ; Song JH; Kim ES; Kim HY; Min KW
    Pathol Res Pract; 2018 Jun; 214(6):881-888. PubMed ID: 29650441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic silencing of KAZALD1 confers a better prognosis and is associated with malignant transformation/progression in glioma.
    Wang H; Feng Y; Bao Z; Jiang C; Yan W; Wang Y; Zhang C; Liu Y; Zhang Q; Zhang W; Jiang C
    Oncol Rep; 2013 Nov; 30(5):2089-96. PubMed ID: 24002581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-328 is a favorable prognostic marker in human glioma via suppressing invasive and proliferative phenotypes of malignant cells.
    Yuan J; Zheng Z; Zheng Y; Lu X; Xu L; Lin L
    Int J Neurosci; 2016; 126(2):145-53. PubMed ID: 25562367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma.
    Wang Z; Wang Z; Zhang C; Liu X; Li G; Liu S; Sun L; Liang J; Hu H; Liu Y; Zhang W; Jiang T
    Cancer Sci; 2018 Sep; 109(9):2697-2705. PubMed ID: 30027617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer.
    Fu H; He HC; Han ZD; Wan YP; Luo HW; Huang YQ; Cai C; Liang YX; Dai QS; Jiang FN; Zhong WD
    Tumour Biol; 2015 Mar; 36(3):1983-91. PubMed ID: 25394900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas.
    Li MY; Yang P; Liu YW; Zhang CB; Wang KY; Wang YY; Yao K; Zhang W; Qiu XG; Li WB; Peng XX; Wang YZ; Jiang T
    Sci Rep; 2016 Feb; 6():21141. PubMed ID: 26879272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas.
    Liu N; Wang Z; Cheng Y; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y
    Hum Pathol; 2016 Dec; 58():105-112. PubMed ID: 27574811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival.
    Fogli A; Chautard E; Vaurs-Barrière C; Pereira B; Müller-Barthélémy M; Court F; Biau J; Pinto AA; Kémény JL; Khalil T; Karayan-Tapon L; Verrelle P; Costa BM; Arnaud P
    Carcinogenesis; 2016 Feb; 37(2):169-176. PubMed ID: 26717998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypomethylated Rab27b is a progression-associated prognostic biomarker of glioma regulating MMP-9 to promote invasion.
    Wang H; Wang Y; Bao Z; Zhang C; Liu Y; Cai J; Jiang C
    Oncol Rep; 2015 Sep; 34(3):1503-9. PubMed ID: 26165699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
    Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
    EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.
    Reich TR; Switzeny OJ; Renovanz M; Sommer C; Kaina B; Christmann M; Tomicic MT
    Oncotarget; 2017 Feb; 8(9):15071-15084. PubMed ID: 28122345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell division cycle associated 7 like predicts unfavorable prognosis and promotes invasion in glioma.
    Shen FZ; Li XS; Ma JW; Wang XY; Zhao SP; Meng L; Liang SF; Zhao XL
    Pathol Res Pract; 2019 Jan; 215(1):50-56. PubMed ID: 30389317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
    Schliesser MG; Claus R; Hielscher T; Grimm C; Weichenhan D; Blaes J; Wiestler B; Hau P; Schramm J; Sahm F; Weiß EK; Weiler M; Baer C; Schmidt-Graf F; Schackert G; Westphal M; Hertenstein A; Roth P; Galldiks N; Hartmann C; Pietsch T; Felsberg J; Reifenberger G; Sabel MC; Winkler F; von Deimling A; Meisner C; Vajkoczy P; Platten M; Weller M; Plass C; Wick W
    Oncotarget; 2016 Dec; 7(50):82028-82045. PubMed ID: 27880937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis using methylation and gene expression microarrays reveals PDE4C as a prognostic biomarker in human glioma.
    Bao Z; Feng Y; Wang H; Zhang C; Sun L; Yan Z; Liu Q; Guo T; Li M; Yang X; Jiang C; Zhang Q; Jiang T
    Oncol Rep; 2014 Jul; 32(1):250-60. PubMed ID: 24842301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CACNA2D3 is downregulated in gliomas and functions as a tumor suppressor.
    Jin Y; Cui D; Ren J; Wang K; Zeng T; Gao L
    Mol Carcinog; 2017 Mar; 56(3):945-959. PubMed ID: 27583705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p14ARF promoter region methylation as a marker for gliomas diagnosis.
    He J; Qiao JB; Zhu H
    Med Oncol; 2011 Dec; 28(4):1218-24. PubMed ID: 20714943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of 5'-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness.
    Menezes WP; Silva VAO; Gomes INF; Rosa MN; Spina MLC; Carloni AC; Alves ALV; Melendez M; Almeida GC; Silva LSD; Clara C; da Cunha IW; Hajj GNM; Jones C; Bidinotto LT; Reis RM
    Cells; 2020 Feb; 9(2):. PubMed ID: 32093414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.